Have questions about CUVITRU® and PI?

We have answers to the most frequently asked questions. Be sure to ask your doctor any additional questions you may have.

About CUVITRU

CUVITRU is a liquid medicine that contains immunoglobulin (Ig) antibodies, which help protect your body against infection.1
CUVITRU is given under the skin (subcutaneously) to treat primary immunodeficiency (PI) in people 2 years and older.1

Syringe Driver Pump Desktop
  1.  
  2.  
  3.  
  4.  
Infusion supplies icon.
  1. Syringe driver pump: pushes CUVITRU from the syringe
  2. Flow rate tubing: controls the infusion speed of CUVITRU
  3. Needle set: infuses CUVITRU into the subQ space
  4. Needle gauge: helps achieve the desired infusion rate of CUVITRU*
    *To achieve the maximum infusion rate of 60 mL/hour/site with CUVITRU, you'll need a 24-gauge needle.

Store CUVITRU in the refrigerator at 36°F to 46°F (2°C to 8°C) for up to 36 months, or at room temperature, not to exceed 77°F (25°C), for up to 24 months. Do not return CUVITRU to the refrigerator if you take it out to room temperature. Do not freeze. Do not shake. Do not use past the expiration date. Protect from light. You can use the original CUVITRU containers to protect it from light.1

Side effects

CUVITRU can cause the following serious reactions1:

  • Severe allergic reactions causing difficulty in breathing or skin rashes
  • Decreased kidney function or kidney failure
  • Blood clots in the heart, brain, lungs, or elsewhere in the body
  • Severe headache, drowsiness, fever, painful eye movements, or nausea and vomiting
  • Dark colored urine, swelling, fatigue, or difficulty breathing

Do not use CUVITRU if you have a known history of a severe allergic reaction to immune globulin or other blood products. If you have such a history, discuss this with your healthcare provider to determine if CUVITRU can be given to you. Tell your healthcare provider if you have a condition called selective (or severe) immunoglobulin A (IgA) deficiency.1

CUVITRU can cause serious side effects. If any of the following problems occur after starting CUVITRU, stop the infusion immediately and contact your doctor or call emergency services (911)1:

  • Hives, swelling in the mouth or throat, itching, trouble breathing, wheezing, fainting, or dizziness. These could be signs of a serious allergic reaction
  • Bad headache with nausea, vomiting, stiff neck, fever, and sensitivity to light. These could be signs of irritation and swelling of the lining around your brain
  • Reduced urination, sudden weight gain, or swelling in your legs. These could be signs of a kidney problem
  • Pain, swelling, warmth, redness, or a lump in your legs or arms. These could be signs of a blood clot
  • Brown or red urine, fast heart rate, yellow skin or eyes. These could be signs of a liver problem or a blood problem
  • Chest pain or trouble breathing, or blue lips or extremities. These could be signs of a serious heart or lung problem
  • Fever over 100°F. This could be a sign of an infection

The following one or more possible reactions may occur at the site of infusion. These generally go away within a few hours and are less likely after the first few infusions.

  • Mild or moderate pain
  • Redness
  • Itching

The most common side effects with CUVITRU are:

  • Headache
  • Nausea
  • Fatigue
  • Diarrhea
  • Vomiting

Support FAQs

CUVITRU is covered under many commercial health plans. Ask your provider’s office staff to help explain out-of-pocket costs. Takeda Patient Support offers support to patients prescribed a Takeda Ig and enrolled in the program. We’ll also help you understand what’s covered, what’s not, and what to do next.

If you are enrolled, the Takeda Patient Support Co-Pay Assistance Program can help you save on CUVITRU.*

The program can cover up to 100% of your out-of-pocket co-pay costs, if you’re eligible. To be eligible for this program, you must:

  1. Be prescribed a Takeda treatment for a condition it’s approved by the Food and Drug Administration (FDA) to treat. This is called an “approved indication.” Ask your doctor if you’re not sure.
  2. Have commercial insurance. This includes Health Insurance Marketplace plans.
  3. Commercial insurance does not include Medicare, Medicaid, Veterans Affairs (VA), or other federal or state health plans
  4. Be enrolled in Takeda Patient Support.

*IMPORTANT NOTICE: The Takeda Patient Support Co-Pay Assistance Program (the Program) is not valid for prescriptions eligible to be reimbursed, in whole or in part, by Medicaid, Medicare (including Medicare Part D), Tricare, Medigap, VA, DoD, or other federal or state programs (including any medical or state prescription drug assistance programs). No claim for reimbursement of the out-of-pocket expense amount covered by the Program shall be submitted to any third party payer, whether public or private. The Program cannot be combined with any other rebate/coupon, free trial, or similar offer. Copayment assistance under the Program is not transferable. The Program only applies in the United States, including Puerto Rico and other U.S. territories, and does not apply where prohibited by law, taxed, or restricted. This does not constitute health insurance. Void where use is prohibited by your insurance provider. If your insurance situation changes you must notify the Program immediately at 1-866-861-1750. Coverage of certain administration charges will not apply for patients residing in states where it is prohibited by law. Takeda reserves the right to rescind, revoke, or amend the Program at any time without notice.

Primary immunodeficiency is considered a complex and rare disease, and the treatments are considered specialty drugs. CUVITRU is a specialty drug, and only select specialty pharmacy providers (SPPs) have this medication in stock. So, your doctor’s office will order CUVITRU through an SPP.

Rather than pick up your prescription at a retail pharmacy in your neighborhood, specialty drugs are mailed to your home or your doctor’s office. You may be contacted by the SPP to coordinate the delivery.

Financial questions and concerns

Your costs for CUVITRU will depend on many factors, including your pharmacy provider and your insurance plan. When you’re prescribed CUVITRU, Takeda Patient Support is dedicated to helping you get the answers, resources, and tools you need. Some of the ways we can help include:

  • Enrolling you in the Takeda Patient Support Co-Pay Assistance Program, if you qualify*
  • Offering support by walking you through the insurance process step by step

If you have government insurance, we are here to help answer questions about your prescribed Takeda treatment coverage. This includes federal or state insurance such as Medicare, Medicare Advantage, or Medicaid. If you can’t afford your treatment, we may be able to connect you to programs that may help.

*To be eligible, you must be enrolled in Takeda Patient Support and have commercial insurance. Other terms and conditions apply. Call us for more details at 1-866-861-1750, Monday through Friday, 8 AM to 8 PM ET.

If you are enrolled, the Takeda Patient Support Co-Pay Assistance Program can help you save on CUVITRU.*

The program can cover up to 100% of your out-of-pocket co-pay costs, if you’re eligible. To be eligible for this program, you must:

  1. Be prescribed a Takeda treatment for a condition it’s approved by the Food and Drug Administration (FDA) to treat. This is called an “approved indication.” Ask your doctor if you’re not sure.
  2. Have commercial insurance. This includes Health Insurance Marketplace plans.
  3. Commercial insurance does not include Medicare, Medicaid, Veterans Affairs (VA), or other federal or state health plans
  4. Be enrolled in Takeda Patient Support.

*IMPORTANT NOTICE: The Takeda Patient Support Co-Pay Assistance Program (the Program) is not valid for prescriptions eligible to be reimbursed, in whole or in part, by Medicaid, Medicare (including Medicare Part D), Tricare, Medigap, VA, DoD, or other federal or state programs (including any medical or state prescription drug assistance programs). No claim for reimbursement of the out-of-pocket expense amount covered by the Program shall be submitted to any third party payer, whether public or private. The Program cannot be combined with any other rebate/coupon, free trial, or similar offer. Copayment assistance under the Program is not transferable. The Program only applies in the United States, including Puerto Rico and other U.S. territories, and does not apply where prohibited by law, taxed, or restricted. This does not constitute health insurance. Void where use is prohibited by your insurance provider. If your insurance situation changes you must notify the Program immediately at 1-866-861-1750. Coverage of certain administration charges will not apply for patients residing in states where it is prohibited by law. Takeda reserves the right to rescind, revoke, or amend the Program at any time without notice.

Insurance

CUVITRU is covered similarly to other treatments of primary immunodeficiency, but coverage may vary by plan. Your infusion provider may be able to help explain out-of-pocket costs. Takeda Patient Support also offers insurance and financial support by walking you through the insurance process step by step. We’ll also help you understand what’s covered, what’s not, and what to do next.

PI FAQs

References

1. CUVITRU. Prescribing Information, Takeda Pharmaceuticals USA Inc.; 2023.

2. Gelfand EF. Differences between IGIV products: impact on clinical outcome. Int Immunopharmacol. 2006;6:592-599.